A detailed history of Scott Investment Partners LLP transactions in Biogen Inc. stock. As of the latest transaction made, Scott Investment Partners LLP holds 3,100 shares of BIIB stock, worth $461,962. This represents 1.83% of its overall portfolio holdings.

Number of Shares
3,100
Previous 3,100 -0.0%
Holding current value
$461,962
Previous $883,000 9.74%
% of portfolio
1.83%
Previous 1.99%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 21, 2021

BUY
$242.95 - $284.63 $121,475 - $142,315
500 Added 19.23%
3,100 $867,000
Q4 2020

Jan 28, 2021

BUY
$236.26 - $355.63 $614,276 - $924,638
2,600 New
2,600 $637,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Scott Investment Partners LLP Portfolio

Follow Scott Investment Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scott Investment Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Scott Investment Partners LLP with notifications on news.